Cobalt Test

If you have a metal hip implant, work around hard metals or alloys, or simply want to know whether environmental exposure is silently raising your risk of heart disease, your blood cobalt level is the number that answers that question. Most people never think about cobalt, but large population studies now link even modest elevations to higher rates of cardiovascular death and overall mortality.

Cobalt sits at the center of vitamin B12, and in that form it is essential. But free cobalt ions, the kind released from corroding joint implants or inhaled in industrial settings, are a different story. They interfere with energy production inside cells, disrupt thyroid hormones, and can progressively damage heart muscle, nerve tissue, and vision. Your blood cobalt level tells you how much of this metal is circulating in your body right now.

Why Blood Cobalt Matters for Heart Health

A study of over 15,800 U.S. adults tracked for roughly 11 years found that people with higher urinary cobalt levels had about 30% greater risk of dying from cardiovascular disease (a measure of heart attacks, strokes, and heart failure combined) after adjusting for age, smoking, BMI, and other standard risk factors. For blood cobalt, the signal was even stronger: each unit increase on a logarithmic scale (a way of compressing a wide range of values into a more manageable scale) was linked to roughly double the risk of cardiovascular death.

The MESA study (Multi-Ethnic Study of Atherosclerosis), which followed about 6,600 adults free of heart disease for up to 19 years, found that people in the highest quarter of urinary cobalt had about 24% higher risk of developing cardiovascular disease and 37% higher risk of dying from any cause compared to those in the lowest quarter. These associations held after accounting for standard cardiovascular risk factors like cholesterol, blood pressure, and diabetes.

A separate analysis of about 14,300 adults using mixture modeling (a method that evaluates multiple metals simultaneously) confirmed that urinary cobalt independently contributed to all-cause and cardiovascular mortality, with roughly 21% and 29% increased risk per log-unit increase, respectively. What makes these findings striking is that they describe environmental-level exposure, not extreme industrial or implant-related poisoning.

Cobalt Toxicity from Hip Implants

The most dramatic cobalt-related health problems occur in people with cobalt-chromium hip implants. When these implants wear or corrode, cobalt ions leak into the bloodstream. A systematic review of 79 patients found that the most common symptoms involved the nervous system (about 43% of all reported symptoms), followed by the cardiovascular system (about 22%). Neurological effects include hearing loss, vision problems, memory impairment, tremor, and peripheral nerve damage. Cardiovascular effects center on a distinctive form of heart muscle damage called dilated cardiomyopathy, where the heart chambers stretch and weaken.

Blood cobalt levels in patients with metal-on-metal bearings who developed toxicity averaged about 124 µg/L. In patients whose ceramic implant was revised to a metal head (where ceramic fragments grind against the new metal surface), average levels were roughly ten times higher, around 1,078 µg/L. Fatal outcomes, while rare, have been reported, including cases requiring heart transplant.

A prospective blinded study of 229 patients with cobalt-chromium implants found that urine cobalt at or above 1 ppb (parts per billion) correctly identified symptomatic cobalt toxicity about 69% of the time and correctly ruled it out about 77% of the time. Brain imaging with a technique called FDG-PET (which measures how actively different brain regions use energy) showed that neurological damage from cobalt follows a pattern of reduced brain activity, most pronounced in the temporal and frontal regions, similar to the pattern seen with other heavy metal exposures. This damage was detected at blood cobalt levels as low as 0.4 µg/L.

Other Health Associations

Beyond heart disease and neurotoxicity, elevated cobalt has been linked to thyroid dysfunction (underactive thyroid and goiter), excess red blood cell production (a condition called polycythemia), and anemia at lower exposure levels. A cross-sectional study using NHANES data found that each 1 nmol/L increase in blood cobalt was associated with 36% higher odds of anemia. The relationship between cobalt and cardiovascular disease subtypes showed a curved pattern rather than a straight line, with stronger associations below a turning point of about 3.94 nmol/L (roughly 0.23 µg/L).

Cross-sectional data from about 3,400 U.S. adults showed that those in the highest quarter of serum cobalt had about 74% higher prevalence of cardiovascular disease compared to those in the lowest quarter, with the association following a positive, curved relationship. Higher cobalt levels have also been associated with kidney stones, gallstones, and insulin resistance in some analyses, though these findings are cross-sectional and cannot prove causation.

Reference Ranges

There is no single universally accepted set of clinical cutpoints for blood cobalt. The ranges below synthesize guidance from regulatory bodies and published research. They are measured in whole blood using a technique called ICP-MS (inductively coupled plasma mass spectrometry), which detects very small concentrations of metals, and reported in µg/L (micrograms per liter). Your lab may report different units or use slightly different thresholds.

Compare your results within the same lab over time for the most meaningful trend. The MHRA threshold of 7 µg/L and the Mayo Clinic's suggested serum threshold of 10 µg/L were designed primarily to flag implant wear, not to define systemic toxicity thresholds for the general population.

Who Has Higher Levels

NHANES biomonitoring data show that women tend to have slightly higher blood cobalt than men, and people with metal objects inside their bodies (such as joint implants, screws, or dental hardware) have statistically higher blood cobalt than those without. A study of over 4,400 U.S. adults aged 40 and older found that having metal objects in the body was associated with 0.42 nmol/L higher blood cobalt on average. Ethnicity-based differences have been reported but are modest and not consistent enough to drive separate reference ranges.

When Results Can Be Misleading

Blood cobalt reflects recent and ongoing exposure, not lifetime accumulation. A single reading can be influenced by several factors:

• Vitamin B12 supplements: High-dose B12 supplements contain cobalt within the B12 molecule. While this form is generally not toxic, it can raise total blood cobalt readings slightly, potentially making your result harder to interpret in the context of environmental exposure.
• Kidney function: Cobalt is partly cleared through the kidneys. Impaired kidney function can slow elimination and raise blood levels without any increase in actual exposure.
• Recent dietary intake: Foods high in cobalt include leafy greens, nuts, fish, and fortified cereals. A meal unusually rich in these foods shortly before testing is unlikely to cause a large shift, but it may nudge a borderline result.
• Contamination during collection: Cobalt is present in many metal needles and collection tubes. Labs that measure trace metals use special metal-free collection equipment. If your sample was drawn with standard equipment, results may be falsely elevated.